scispace - formally typeset
B

Bing Sun

Researcher at Chinese Academy of Sciences

Publications -  172
Citations -  6144

Bing Sun is an academic researcher from Chinese Academy of Sciences. The author has contributed to research in topics: Virus & Antibody. The author has an hindex of 41, co-authored 139 publications receiving 4887 citations. Previous affiliations of Bing Sun include Shanghai University & University of Science and Technology of China.

Papers
More filters
Journal ArticleDOI

Nitric oxide suppresses NLRP3 inflammasome activation and protects against LPS-induced septic shock

TL;DR: This work finds that curcumin potently inhibits the activation of NLRP3 inflammasome which may contribute to its anti-inflammatory activity and offers a mechanistic basis for the therapeutic potential ofCurcumin in septic shock and other NLRP2 inflammaome-driven diseases.
Journal ArticleDOI

TRIM30 alpha negatively regulates TLR-mediated NF-kappa B activation by targeting TAB2 and TAB3 for degradation.

TL;DR: It is indicated that TRIM30α negatively regulates TLR-mediated NF-κB activation by targeting degradation of TAB2 and TAB3 by a 'feedback' mechanism.
Journal ArticleDOI

Unusual architecture of the p7 channel from hepatitis C virus

TL;DR: The structures of this HCV viroporin as well as its drug-binding site are determined using the latest nuclear magnetic resonance (NMR) technologies to provide a molecular explanation for p7-mediated cation conductance and its inhibition by adamantane derivatives.
Journal ArticleDOI

Kaempferol derivatives as antiviral drugs against the 3a channel protein of coronavirus.

TL;DR: It is suggested that viral ion channels, in general, may be a good target for the development of antiviral agents, and that kaempferol glycosides are good candidates for 3a channel proteins of coronaviruses.
Journal ArticleDOI

Antibody responses to individual proteins of SARS coronavirus and their neutralization activities.

TL;DR: It is suggested that anti-S and anti-N antibodies are diagnostic markers and in particular that S3 is immunogenic and therefore is a good candidate as a subunit vaccine antigen; and that, from a virus structure viewpoint, the presence in some human sera of antibodies reacting with two recombinant polypeptides, 3a and 9b, supports the hypothesis that they are synthesized during the virus cycle.